How Do Medical Device Companies View Risk-Based Monitoring and Does It Differ from Pharmaceuticals?
When it comes to risk-based monitoring (RBM) in clinical research, how are studies conducted by medical device companies different from pharma studies? Medtronic International's Nurcan Coskun shares her thoughts, in the first of this two-part video series.*Guest blogger Nurcan Coskun is the district monitoring manager across Europe for clinical operations at Medtronic International. TWEET THIS:
— Medidata (@Medidata) January 16, 2015